Literature DB >> 1396900

Megadose methylprednisolone for diffuse infantile haemangiomatosis.

S Ozsoylu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1396900     DOI： 10.1007/bf02113268

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

1.  High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura.

Authors:  S Ozsoylu; G Irken; A Karabent
Journal:  Eur J Haematol       Date:  1989-05       Impact factor: 2.997

2.  Diffuse infantile haemangiomatosis: clinicopathological features and management problems in five fatal cases.

Authors:  R W Byard; P E Burrows; T Izakawa; M M Silver
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

3.  High dose intravenous methylprednisolone for Kassabach-Merritt syndrome.

Authors:  S Ozsoylu; G Irken; A Gürgey
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183
  3 in total
  2 in total

1.  Megadose methylprednisolone for Kasabach-Merritt syndrome.

Authors:  S Ozsoylu
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

2.  Megadose Methylprednisolone (MDMP) for Hemangiomatosis.

Authors:  Sinasi Ozsoylu
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.